Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

321
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
321
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

652
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
652
Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

1.2K
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
1.2K
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

310
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
310
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

904
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
904
Methods of Medium Optimization01:28

Methods of Medium Optimization

15
Optimizing growth media enhances microbial proliferation and maximizes product yield. Statistical experimental design methodologies provide structured and reproducible approaches, offering progressively higher levels of robustness and efficiency.The One-Factor-at-a-Time (OFAT) MethodThe One-Factor-at-a-Time (OFAT) method involves adjusting a single variable while keeping all others constant. However, it cannot detect interactions between variables, often leading to suboptimal outcomes when...
15

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Complications of lymph node dissection in thyroid cancer].

Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen·2020
Same author

Endothelin B receptors targeted by iron oxide nanoparticles functionalized with a specific antibody: toward immunoimaging of brain tumors.

Journal of materials chemistry. B·2020
Same author

Optimization of pegylated iron oxide nanoplatforms for antibody coupling and bio-targeting.

Journal of materials chemistry. B·2020
Same author

Account of an Organic Disease of the Heart.

The Medical and physical journal·2018
Same author

Effects of sporidesmin on cultured biliary tract cells from Romney lambs that differed in their sensitivity to sporidesmin.

New Zealand veterinary journal·2018
Same author

Genetically tailored magnetosomes used as MRI probe for molecular imaging of brain tumor.

Biomaterials·2017

Related Experiment Video

Updated: Mar 24, 2026

Meta-analysis of Voxel-Based Neuroimaging Studies using Seed-based d Mapping with Permutation of Subject Images SDM-PSI
06:26

Meta-analysis of Voxel-Based Neuroimaging Studies using Seed-based d Mapping with Permutation of Subject Images SDM-PSI

Published on: November 27, 2019

79.1K

The Many Flavors of Model-Based Meta-Analysis: Part I-Introduction and Landmark Data.

M Boucher1, M Bennetts1

  • 1Pharmacometrics, Pfizer Ltd Sandwich Kent UK.

CPT: Pharmacometrics & Systems Pharmacology
|March 3, 2016
PubMed
Summary
This summary is machine-generated.

This tutorial introduces model-based meta-analysis (MBMA) for drug development. It covers classical and Bayesian methods for analyzing landmark data, crucial for benchmarking compounds.

More Related Videos

Author Spotlight: Emerging Technologies and Advanced Tools for Decoding Metabolomics Data Analysis
07:11

Author Spotlight: Emerging Technologies and Advanced Tools for Decoding Metabolomics Data Analysis

Published on: November 10, 2023

3.5K
Large-Scale Multi-Omics Genome-Wide Association Studies Mo-GWAS: Guidelines for Sample Preparation and Normalization
08:27

Large-Scale Multi-Omics Genome-Wide Association Studies Mo-GWAS: Guidelines for Sample Preparation and Normalization

Published on: July 27, 2021

5.0K

Related Experiment Videos

Last Updated: Mar 24, 2026

Meta-analysis of Voxel-Based Neuroimaging Studies using Seed-based d Mapping with Permutation of Subject Images SDM-PSI
06:26

Meta-analysis of Voxel-Based Neuroimaging Studies using Seed-based d Mapping with Permutation of Subject Images SDM-PSI

Published on: November 27, 2019

79.1K
Author Spotlight: Emerging Technologies and Advanced Tools for Decoding Metabolomics Data Analysis
07:11

Author Spotlight: Emerging Technologies and Advanced Tools for Decoding Metabolomics Data Analysis

Published on: November 10, 2023

3.5K
Large-Scale Multi-Omics Genome-Wide Association Studies Mo-GWAS: Guidelines for Sample Preparation and Normalization
08:27

Large-Scale Multi-Omics Genome-Wide Association Studies Mo-GWAS: Guidelines for Sample Preparation and Normalization

Published on: July 27, 2021

5.0K

Area of Science:

  • Pharmacometrics
  • Drug Development
  • Biostatistics

Background:

  • Meta-analysis is vital in drug development for competitive benchmarking.
  • Diverse analyses are possible, from preclinical to post-registration stages.
  • This tutorial series focuses on model-based meta-analysis (MBMA).

Purpose of the Study:

  • To provide a foundational understanding of MBMA methods.
  • To introduce classical and Bayesian approaches for landmark data analysis.
  • To guide researchers in applying MBMA to drug development questions.

Main Methods:

  • Introduction to model-based meta-analysis (MBMA) concepts.
  • Explanation of classical statistical methods for meta-analysis.
  • Overview of Bayesian meta-analysis techniques for landmark data.

Main Results:

  • N/A - This is an introductory tutorial, not a research study with results.
  • Focuses on methodology rather than empirical findings.
  • Provides a framework for future meta-analysis studies.

Conclusions:

  • MBMA offers a flexible framework for analyzing drug development data.
  • Classical and Bayesian methods are applicable to landmark data.
  • This tutorial serves as a basis for advanced MBMA applications.